Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

A randomized, double-blind, placebo-controlled trial of camicinal in Parkinson's disease.

Journal article

Marrinan SL. et al, (2018), Mov disord, 33, 329 - 332

Mutant Mice With Calcium-Sensing Receptor Activation Have Hyperglycemia That Is Rectified by Calcilytic Therapy.

Journal article

Babinsky VN. et al, (2017), Endocrinology, 158, 2486 - 2502

Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component.

Journal article

Richards DB. et al, (2015), N engl j med, 373, 1106 - 1114

Target mediated drug disposition model of CPHPC in patients with systemic amyloidosis

Journal article

Sahota T. et al, (2015), Cpt: pharmacometrics and systems pharmacology, 4, 116 - 126

Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.

Journal article

Chamberlain SR. et al, (2012), Psychopharmacology (berl), 224, 501 - 509

Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498.

Journal article

Nathan PJ. et al, (2012), J clin pharmacol, 52, 1456 - 1467

Developing and delivering clinical pharmacology in pharmaceutical companies.

Journal article

Richards D., (2012), British journal of clinical pharmacology, 73, 870 - 873

Load More